ClariTrial | Search Clinical Trials

Explore/Prostate Cancer

Status

Phase

8,507 results for “Prostate Cancer”

Page 1 of 568

Completed

IIT2020-20-SHIRAZIP-WALK: Nature Walks

N/ABreast CancerCancerLymphoma

Nature based exercise

Cedars-Sinai Medical Center20 participants1 site · United StatesCompletes May 2023

Compare CT.gov Full analysis →

Completed

Results posted

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

Phase 1Phase 2Pancreatic CancerMetastatic Castration-resistant Prostate CancerBladder Cancer

NGM120 30mgNGM120 100mgNGM120 30mg with Gemcitabine and Abraxane+3 more

NGM Biopharmaceuticals, Inc89 participants20 sites · United StatesCompletes Sep 2023

Compare CT.gov Full analysis →

UNKNOWN

Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer

N/AProstate Cancer Recurrent

Institute of Cancer Research, United Kingdom50 participants1 site · United KingdomCompletes Sep 2022

Compare CT.gov Full analysis →

UNKNOWN

5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:

N/AProstate Cancer

Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5

Sunnybrook Health Sciences Centre75 participants1 site · CanadaCompletes Aug 2021

Compare CT.gov Full analysis →

Completed

Results posted

PROState Pathway Embedded Comparative Trial

N/AProstate CancerNon-metastatic Prostate CancerMetastatic Prostate Cancer

Imperial College London139 participants3 sites · United KingdomCompletes Aug 2022

Compare CT.gov Full analysis →

Completed

A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.

Phase 1Metastatic Castration Resistant Prostate Cancer

HC-1119

Hinova Pharmaceuticals Inc.43 participants1 site · ChinaCompletes Sep 2018

Compare CT.gov Full analysis →

Completed

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

N/AProstate Cancer

DutasteridePlacebo

University of Illinois at Chicago139 participants1 site · United StatesCompletes Nov 2015

Compare CT.gov Full analysis →

Completed

Duke Urology Database and Specimen Bank

N/AProstate CancerBladder CancerErectile Dysfunction

Duke University87,820 participants1 site · United StatesCompletes Nov 2012

Compare CT.gov Full analysis →

Terminated

Pre-Prostatectomy Celecoxib or Placebo

Phase 2Adenocarcinoma of the ProstateProstate Cancer

CelecoxibPlacebo

OHSU Knight Cancer Institute34 participants2 sites · United StatesCompletes Jan 2005

Compare CT.gov Full analysis →

Terminated

A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer

Phase 2Prostatic Neoplasms

Degarelix

Ottawa Hospital Research Institute5 participants3 sites · CanadaCompletes Oct 2011

Compare CT.gov Full analysis →

Not Yet Recruiting

Minimal Residual Disease in Solid Malignancies

N/ABreast CancerNon Small Cell Lung CancerProstate Cancer

ctDNA detection

European Institute of Oncology840 participantsCompletes Jul 2033

Compare CT.gov Full analysis →

Withdrawn

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Phase 2Castrate-resistant Metastatic Prostate Cancer

CabazitaxelPrednisoneGranulocyte colony-stimulating factor (G-CSF)

Case Comprehensive Cancer Center0Completes Oct 2013

Compare CT.gov Full analysis →

Active

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Phase 1Phase 2Advanced Solid Tumor

DB-1305/BNT325PembrolizumabBNT327

DualityBio Inc.1,123 participants93 sites · United States, China, Puerto RicoCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

In Vivo Dosimetry for Brachytherapy Study

N/AProstate CancerGynaecological Cancer

East and North Hertfordshire NHS Trust20 participants1 site · United KingdomCompletes Mar 2026

Compare CT.gov Full analysis →

Completed

Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate

Phase 2Prostate Cancer

soy isoflavonesneoadjuvant therapyPlacebo

Barbara Ann Karmanos Cancer Institute32 participants1 site · United StatesCompletes May 2010

Compare CT.gov Full analysis →

1–15 of 8,507

Explore/Prostate Cancer

Status

Phase

8,507 results for “Prostate Cancer”

Page 1 of 568

Completed

IIT2020-20-SHIRAZIP-WALK: Nature Walks

N/ABreast CancerCancerLymphoma

Nature based exercise

Cedars-Sinai Medical Center20 participants1 site · United StatesCompletes May 2023

Compare CT.gov Full analysis →

Completed

Results posted

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

Phase 1Phase 2Pancreatic CancerMetastatic Castration-resistant Prostate CancerBladder Cancer

NGM120 30mgNGM120 100mgNGM120 30mg with Gemcitabine and Abraxane+3 more

NGM Biopharmaceuticals, Inc89 participants20 sites · United StatesCompletes Sep 2023

Compare CT.gov Full analysis →

UNKNOWN

Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer

N/AProstate Cancer Recurrent

Institute of Cancer Research, United Kingdom50 participants1 site · United KingdomCompletes Sep 2022

Compare CT.gov Full analysis →

UNKNOWN

5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:

N/AProstate Cancer

Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5

Sunnybrook Health Sciences Centre75 participants1 site · CanadaCompletes Aug 2021

Compare CT.gov Full analysis →

Completed

Results posted

PROState Pathway Embedded Comparative Trial

N/AProstate CancerNon-metastatic Prostate CancerMetastatic Prostate Cancer

Imperial College London139 participants3 sites · United KingdomCompletes Aug 2022

Compare CT.gov Full analysis →

Completed

A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.

Phase 1Metastatic Castration Resistant Prostate Cancer

HC-1119

Hinova Pharmaceuticals Inc.43 participants1 site · ChinaCompletes Sep 2018

Compare CT.gov Full analysis →

Completed

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

N/AProstate Cancer

DutasteridePlacebo

University of Illinois at Chicago139 participants1 site · United StatesCompletes Nov 2015

Compare CT.gov Full analysis →

Completed

Duke Urology Database and Specimen Bank

N/AProstate CancerBladder CancerErectile Dysfunction

Duke University87,820 participants1 site · United StatesCompletes Nov 2012

Compare CT.gov Full analysis →

Terminated

Pre-Prostatectomy Celecoxib or Placebo

Phase 2Adenocarcinoma of the ProstateProstate Cancer

CelecoxibPlacebo

OHSU Knight Cancer Institute34 participants2 sites · United StatesCompletes Jan 2005

Compare CT.gov Full analysis →

Terminated

A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer

Phase 2Prostatic Neoplasms

Degarelix

Ottawa Hospital Research Institute5 participants3 sites · CanadaCompletes Oct 2011

Compare CT.gov Full analysis →

Not Yet Recruiting

Minimal Residual Disease in Solid Malignancies

N/ABreast CancerNon Small Cell Lung CancerProstate Cancer

ctDNA detection

European Institute of Oncology840 participantsCompletes Jul 2033

Compare CT.gov Full analysis →

Withdrawn

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Phase 2Castrate-resistant Metastatic Prostate Cancer

CabazitaxelPrednisoneGranulocyte colony-stimulating factor (G-CSF)

Case Comprehensive Cancer Center0Completes Oct 2013

Compare CT.gov Full analysis →

Active

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Phase 1Phase 2Advanced Solid Tumor

DB-1305/BNT325PembrolizumabBNT327

DualityBio Inc.1,123 participants93 sites · United States, China, Puerto RicoCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

In Vivo Dosimetry for Brachytherapy Study

N/AProstate CancerGynaecological Cancer

East and North Hertfordshire NHS Trust20 participants1 site · United KingdomCompletes Mar 2026

Compare CT.gov Full analysis →

Completed

Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate

Phase 2Prostate Cancer

soy isoflavonesneoadjuvant therapyPlacebo

Barbara Ann Karmanos Cancer Institute32 participants1 site · United StatesCompletes May 2010

Compare CT.gov Full analysis →

1–15 of 8,507